Clinical Trial Update: A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial [Phase 2]

View source ↗

Summary

Phase 2 INSPIRE trial evaluating whether adding durvalumab to chemotherapy and radiation improves outcomes in bladder urothelial carcinoma with lymph node invol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Urothelial Carcinoma

Drugs mentioned

• durvalumab (MEDI4736) (durvalumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Bladder Urothelial Carcinoma, Stage III Bladder Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING